GAO’s reports and testimonies give Congress, federal agencies, and the public timely, fact-based, non-partisan information that can improve government operations and save taxpayers billions of dollars.
Each year, we make more than 1,000 recommendations to help improve the federal government. We alert department heads to the recommendations where they can save the most money, address issues on our High Risk List, or significantly improve government operations.
What GAO Found USDA's Assessment of the National Finance Center Data Center did not comprehensively address the cost-effectiveness, security, and demonstrated history of maintaining continuity of operations functions, as part of its cost-benefit assessment of selected data centers, as directed by the...
What GAO Found The four departments—Agriculture (USDA), Education (Education), Health and Human Services (HHS), and Labor (DOL)—and their selected components used guidance for multiple purposes, such as clarifying or interpreting regulations and providing grant administration information.
What GAO Found The Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) have taken steps to implement GPRA Modernization Act of 2010 (GPRAMA) requirements but could more fully address crosscutting food safety efforts.
What GAO Found The Food and Drug Administration's (FDA) most recent data from 2008 through 2012 show that pesticide residue violation rates in 10 selected fruits and vegetables were low, but FDA's approach to monitoring for violations, which targets commodities it has identified as high risk, has limitations....
This testimony examines issues related to food and agriculture emergencies. Agriculture is critical to public health and the nation's economy. It annually produces $300 billion worth of food and other farm products and is estimated to be responsible for 1 out of every 12 U.S. jobs.
This report reviews the challenges facing U.S. agricultural biotechnology products in international trade. GAO found that new regulations and guidelines that may restrict U.S. exports of crops with a large biotech component are being enacted or considered by some U.S.